Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination

    Picture of Genmab A/S logoGenmab A/S
    11/06/2026 15:48
    BRIEF-Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination
    June 11 (Reuters) - Genmab A/S GMAB.CO:
    • PRESENTS EPCORE FL-1 SUBGROUP DATA DEMONSTRATING CONSISTENT EFFICACY AND SAFETY RESULTS FOR EPCORITAMAB IN COMBINATION WITH RITUXIMAB AND LENALIDOMIDE (R2) ACROSS RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) PATIENTS
    • EPCORITAMAB WITH RITUXIMAB AND LENALIDOMIDE SHOWS SUSTAINED EFFICACY AND MANAGEABLE SAFETY
    Source text: ID:nBw4KyhV7a
    Further company coverage: GMAB.CO

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Genmab A/S

    See all news